LISVOAY Trademark

Trademark Overview

On Thursday, February 26, 2026, a trademark application was filed for LISVOAY with the United States Patent and Trademark Office. The USPTO has given the LISVOAY trademark a serial number of 99672241. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, February 26, 2026. This trademark is owned by Emerge Bioscience Pte. Ltd.. The LISVOAY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals; pharmaceutical preparations; pharmaceutical products; insulin; insulin lispro; insulin analog; anti-diabetics; pharmaceuticals for treating diabetes; pharmaceutical preparations for treating diabetes; pharmaceutical products for treating diabetes; pharmaceutical preparations, namely, injectable insulin; pharmaceutical preparations, namely, injectable insulin lispro; pharmaceutical preparations, namely, injectable insulin analog; pharmaceutical preparations, namely, injectable anti-diabetics; injectable pharmaceutical preparations for treating diabetes; injectable pharmaceutical products for treating diabetes; injectors sold filled with insulin; insulin injectors sold filled with insulin lispro; insulin injectors sold filled with insulin analog; injectors sold filled with pharmaceuticals for treating diabetes; injectors sold filled with anti-diabetics
lisvoay

General Information

Serial Number99672241
Word MarkLISVOAY
Filing DateThursday, February 26, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, February 26, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Indication of Colors claimedThe color(s) blue is/are claimed as a feature of the mark.
Goods and ServicesPharmaceuticals; pharmaceutical preparations; pharmaceutical products; insulin; insulin lispro; insulin analog; anti-diabetics; pharmaceuticals for treating diabetes; pharmaceutical preparations for treating diabetes; pharmaceutical products for treating diabetes; pharmaceutical preparations, namely, injectable insulin; pharmaceutical preparations, namely, injectable insulin lispro; pharmaceutical preparations, namely, injectable insulin analog; pharmaceutical preparations, namely, injectable anti-diabetics; injectable pharmaceutical preparations for treating diabetes; injectable pharmaceutical products for treating diabetes; injectors sold filled with insulin; insulin injectors sold filled with insulin lispro; insulin injectors sold filled with insulin analog; injectors sold filled with pharmaceuticals for treating diabetes; injectors sold filled with anti-diabetics
Description of MarkThe mark consists of the stylized term “LISVOAY” in blue with two drop-shaped designs in blue above the “Y” and three circles in blue above the drop-shaped designs.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 26, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEmerge Bioscience Pte. Ltd.
Party Type10 - Original Applicant
Legal Entity Type24 - NOT AVAILABLE
AddressSingapore 069535
SG

Trademark Events

Event DateEvent Description
Thursday, February 26, 2026NEW APPLICATION ENTERED
Thursday, February 26, 2026APPLICATION FILING RECEIPT MAILED

Related Keywords

lisvoay insulin pharmaceutical preparations diabetes treating injectable sold injectors filled namely